Laurion Capital Management’s Boston Scientific BSX Stock Holding History

Laurion Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-28,800	Closed	-$2.91M	–	406
2025 Q1	$2.91M	Buy	+28,800	New	+$2.9M	0.07%	131
2022 Q4	–	Sell	-180,500	Closed	-$6.99M	–	429
2022 Q3	$6.99M	Sell	180,500 -79,500	-31%	-$3.19M	0.04%	224
2022 Q2	$9.69M	Buy	260,000 +55,000	+27%	+$2.24M	0.15%	108
2022 Q1	$9.08M	Buy	+205,000	New	+$8.88M	0.11%	123
2021 Q4	–	Sell	-45,000	Closed	-$1.95M	–	571
2021 Q3	$1.95M	Buy	+45,000	New	+$1.99M	0.01%	444
2021 Q2	–	Sell	-38,800	Closed	-$1.5M	–	733
2021 Q1	$1.5M	Buy	+38,800	New	+$1.47M	0.01%	453
2019 Q1	–	Sell	-70,000	Closed	-$2.47M	–	880
2018 Q4	$2.47M	Buy	70,000 +54,900	+364%	+$1.99M	0.04%	413
2018 Q3	$582K	Buy	+15,100	New	+$527K	0.01%	800
2018 Q1	–	Sell	-5,800	Closed	-$144K	–	1353
2017 Q4	$144K	Sell	5,800 -51,500	-90%	-$1.42M	﹤0.01%	1454
2017 Q3	$1.67M	Buy	57,300 +21,300	+59%	+$588K	0.01%	827
2017 Q2	$998K	Buy	+36,000	New	+$955K	0.01%	1031

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Laurion Capital Management's BSX Position: Q2 2025 in Review

Laurion Capital Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 10,528 shares — an estimated $1.06M sold.

Laurion Capital Management first reported a position in BSX in Q3 2015 and held it in 21 quarters. The position peaked at $41.7M in Q2 2019. 1,688 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Laurion Capital Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Laurion Capital Management sold 10,528 Boston Scientific shares in Q2 2025, an estimated $1.06M.
Laurion Capital Management first reported a position in Boston Scientific in Q3 2015 and held it in 21 quarters.
Laurion Capital Management's Boston Scientific position peaked at $41.7M in Q2 2019.
1,688 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Laurion Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.